NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 109 filers reported holding NEWLINK GENETICS CORP in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,189,761,000 | +3089.9% | 439,967 | +3468.3% | 0.00% | – |
| Q4 2017 | $99,996,000 | -20.3% | 12,330 | 0.0% | 0.00% | – |
| Q3 2017 | $125,519,000 | +38.5% | 12,330 | 0.0% | 0.00% | – |
| Q2 2017 | $90,626,000 | -69.5% | 12,330 | 0.0% | 0.00% | – |
| Q1 2017 | $297,153,000 | +182202.5% | 12,330 | +13.9% | 0.00% | – |
| Q3 2016 | $163,000 | +33.6% | 10,830 | 0.0% | 0.00% | – |
| Q2 2016 | $122,000 | -96.8% | 10,830 | -94.9% | 0.00% | -100.0% |
| Q1 2016 | $3,837,000 | -50.2% | 210,830 | -0.4% | 0.00% | -55.6% |
| Q4 2015 | $7,701,000 | +1.5% | 211,630 | 0.0% | 0.01% | +12.5% |
| Q3 2015 | $7,585,000 | -18.7% | 211,630 | +0.4% | 0.01% | -11.1% |
| Q2 2015 | $9,333,000 | +1852.5% | 210,830 | +2315.0% | 0.01% | – |
| Q1 2015 | $478,000 | +42.7% | 8,730 | +3.6% | 0.00% | – |
| Q4 2014 | $335,000 | -95.4% | 8,430 | -96.7% | 0.00% | -100.0% |
| Q1 2014 | $7,294,000 | +45.0% | 256,842 | +12.4% | 0.01% | +33.3% |
| Q4 2013 | $5,030,000 | – | 228,542 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTHWEST WEALTH MANAGEMENT, LLC | 54,282 | $553,000 | 0.77% |
| Redmile Group, LLC | 1,248,700 | $12,712,000 | 0.63% |
| FT Options LLC | 20,796 | $212,000 | 0.32% |
| Perceptive Advisors | 900,000 | $9,162,000 | 0.18% |
| Rhenman & Partners Asset Management AB | 100,000 | $1,018,000 | 0.13% |
| PDT Partners, LLC | 349,981 | $3,563,000 | 0.12% |
| Alambic Investment Management, L.P. | 105,370 | $1,073,000 | 0.12% |
| Endurant Capital Management LP | 36,100 | $367,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 132,154 | $1,345,000 | 0.09% |
| COLUMBUS CIRCLE INVESTORS | 485,848 | $4,946,000 | 0.08% |